Risk of SARS-CoV-2 Infection and COVID-19 ;Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis

Risk of SARS-CoV-2 Infection and COVID-19 ;Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis

Nonsteroidal anti-inflammatory drugs (NSAIDs) were thought to increase the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus entrance into cells. Hence, it was suggested in the media that NSAIDs could lead to a higher risk of infection and/or disease severity. Learners that complete this activity will be able to learn about the existence or absence of this association, the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure of NSAIDs.

  • Provider:American College of Clinical Pharmacology
  • Activity Link: https://www.accp1.org/Members/Continuing_Education/Journal_CE/ACCP1/4Continuing_Education/Journal_CE.aspx?hkey=adecf2ad-e111-4e26-92b5-bbd8ce8fda14
  • Start Date: 2021-12-01 06:00:00
  • End Date: 2021-12-01 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: No
  • Activity Type: Journal-based CE
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.